[Article] Industry Leaders Provide Updated RWE Guidelines; Aetion and Amgen Experts Among Authors

A recent article, published in the Journal of Comparative Effectiveness Research, provides an updated look into the state of real world evidence (RWE), along with suggestions regarding how RWE should be used in the decision-making process. The article also identifies existing gaps in current guidelines.

“In this Perspective article, authors affiliated with Aetion Inc. (NY, USA), Amgen Inc. (CA, USA), the National Institute for Health and Care Excellence (Manchester, UK) and the European Medicines Agency (Amsterdam, The Netherlands) offer researchers and decision-makers a structure to organize the landscape of real-world evidence recommendations and identify consensus and gaps in the current recommendations.” Read more here.

(Source: Ilana Landau, The Evidence Base, 2021)